Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Eugene W. Schwilke"'
Autor:
Deanna L. Kelly, Jennifer R. Schroeder, Denis Bonnet, Eugene W. Schwilke, Marilyn A. Huestis, Catherine Ortemann-Renon, David A. Gorelick, David M. Schwope, Robert S. Goodwin
Publikováno v:
The American Journal on Addictions. 22:510-514
Background and Objectives Δ9-tetrahydrocannabinol (THC) promotes sleep in animals; clinical use of THC is associated with somnolence. Human laboratory studies of oral THC have not shown consistent effects on sleep. We prospectively evaluated self-re
Autor:
Eugene W. Schwilke, Marilyn A. Huestis, Deanna L. Kelly, David A. Gorelick, David M. Schwope, Erin L. Karschner, Robert S. Goodwin
Publikováno v:
Drug and Alcohol Dependence. 125:313-319
Determining time since last cannabis/Δ9-tetrahydrocannabinol (THC) exposure is important in clinical, workplace, and forensic settings. Mathematical models calculating time of last exposure from whole blood concentrations typically employ a theoreti
Autor:
Robert S. Goodwin, David A. Gorelick, Eugene W. Schwilke, Marilyn A. Huestis, William D. Darwin, David M. Schwope, Deanna L. Kelly, Garry Milman
Publikováno v:
Clinical Chemistry. 57:1597-1606
BACKGROUND Oral fluid (OF) testing is increasingly important for drug treatment, workplace, and drugged-driving programs. There is interest in predicting plasma or whole-blood concentrations from OF concentrations; however, the relationship between t
Autor:
Garry Milman, Eugene W. Schwilke, David M. Schwope, Robert S. Goodwin, Deana L. Kelly, Allan J. Barnes, David A. Gorelick, Marilyn A. Huestis
Publikováno v:
Analytical and Bioanalytical Chemistry. 401:599-607
Oral fluid (OF) is an increasingly accepted matrix for drug testing programs, but questions remain about its usefulness for monitoring cannabinoids. Expectorated OF specimens (n = 360) were obtained from 10 adult daily cannabis smokers before, during
Autor:
Harrison G. Pope, Marilyn A. Huestis, William D. Darwin, David A. Gorelick, C. Nora Chiang, Jean Lud Cadet, Eugene W. Schwilke, Rod G. Gullberg
Publikováno v:
Addiction. 106:499-506
Aims To develop and validate empirically a mathematical model for identifying new cannabis use in chronic, daily cannabis smokers. Design Models were based on urinary creatinine‐normalized (CN) cannabinoid excretion in chronic cannabis smokers. Set
Autor:
Marilyn A. Huestis, William D. Darwin, Garry Milman, David A. Gorelick, Deanna L. Kelly, Allan J. Barnes, David M. Schwope, Eugene W. Schwilke, Robert S. Goodwin
Publikováno v:
Clinical Chemistry. 56:1261-1269
BACKGROUND Oral fluid, a promising alternative matrix for drug monitoring in clinical and forensic investigations, offers noninvasive sample collection under direct observation. Cannabinoid distribution into oral fluid is complex and incompletely cha
Autor:
Erin L. Karschner, Eugene W. Schwilke, Robert S. Goodwin, David M. Schwope, William D. Darwin, David A. Gorelick, Marilyn A. Huestis, Ross H. Lowe, Deanna L. Kelly
Publikováno v:
Clinical Chemistry. 55:2180-2189
Background: Δ9-Tetrahydrocannabinol (THC) is the primary psychoactive constituent of cannabis and an active cannabinoid pharmacotherapy component. No plasma pharmacokinetic data after repeated oral THC administration are available. Methods: Six adul
Autor:
Eugene W. Schwilke, Marilyn A. Huestis, Harrison G. Pope, W. David Darwin, Jean Lud Cadet, Ronald I. Herning, Erin L. Karschner, Ross H. Lowe
Publikováno v:
Addiction. 104:2041-2048
Aims To quantify blood Δ9-tetrahydrocannabinol (THC) concentrations in chronic cannabis users over 7 days of continuous monitored abstinence. Participants Twenty-five frequent, long-term cannabis users resided on a secure clinical research unit at t
Autor:
Erin L. Karschner, Marilyn A. Huestis, Ann Marie Gordon, Ronald I. Herning, Eugene W. Schwilke, Ross H. Lowe, Jean Lud Cadet
Publikováno v:
Clinical Chemistry. 55:1188-1195
Background: Whole-blood concentrations of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH) are approximately half of those in plasma due to high plasma protein binding and poor cannabinoid distribution in
Autor:
Eugene W. Schwilke, Eric T. Moolchan, Allan J. Barnes, Marilyn A. Huestis, Sherri L. Kacinko, Edward J. Cone, Michael L. Smith
Publikováno v:
Clinical Chemistry. 54:172-180
Background: Understanding methamphetamine (MAMP) and amphetamine (AMP) excretion in sweat is important for interpreting sweat and hair testing results in judicial, workplace, and drug treatment settings. Methods: Participants (n = 8) received 4 10-mg